BMC GenomicsGenomicsPeer-reviewed journal article
Summarizing Performance for Genome Scale Measurement of miRNA: Reference Samples and Metrics
P. Scott Pine, Steven P. LundiD, Jerod ParsonsiD, Lindsay Vang, Ashish A. MahabaliD, L. Cinquini, Sean C. KellyiD, Heather KincaidiD, Daniel J. CrichtoniD, Avrum E. SpiraiD, Gang LiuiD, Adam C. GoweriD, Harvey Ira PassiD, Chandra M. V. GoparajuiD, Steven M. DubinettiD, Kostyantyn KrysaniD, Sanford A. Stass, Debra L. Kukuruga, Kendall R. Van Keuren‐JenseniD, Amanda Courtright-LimiD, Karol L. Thompson, Barry A. Rosenzweig, Lynn R. Sorbara, Sudhir SrivastavaiD, Marc SalitiD
Abstract
BackgroundThe potential utility of microRNA as biomarkers for early detection of cancer and other diseases is being investigated with genome-scale profiling of differentially expressed microRNA. Processes for measurement assurance are critical components of genome-scale measurements. Here, we evaluated the utility of a set of total RNA samples, designed with between-sample differences in the relative abundance of miRNAs, as process controls.\n\nResultsThree pure total human RNA samples (brain, liver, and placenta) and two different mixtures of these components were evaluated as measurement assurance control samples on multiple measurement systems at multiple sites and over multiple rounds. In silico modeling of mixtures provided benchmark values for comparison with physical mixtures. Biomarker development laboratories using next-generation sequencing (NGS) or genome-scale hybridization assays participated in the study and returned data from the samples using their routine workflows. Multiplexed and single assay reverse-transcription PCR (RT-PCR) was used to confirm in silico predicted sample differences. Data visualizations and summary metrics for genome-scale miRNA profiling assessment were developed using this dataset, and a range of performance was observed. These metrics have been incorporated into an online data analysis pipeline and provide a convenient dashboard view of results from experiments following the described design. The website also serves as a repository for the accumulation of performance values providing new participants in the project an opportunity to learn what may be achievable with similar measurement processes.\n\nConclusionsThe set of reference samples used in this study provides benchmark values suitable for assessing genome-scale miRNA profiling processes. Incorporation of these metrics into an online resource allows laboratories to periodically evaluate their performance and assess any changes introduced into their measurement process.
- organism: human
- assay: bulk RNA-seq
- research focus: benchmarking
- approach: statistical model
- approach: benchmark study
- Citations
- 7
- FWCI
- 0.23
- Field percentile
- 42th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Using Mixtures of Biological Samples as Process Controls for RNA-sequencing experiments
Jerod Parsons, Sarah Munro, … Marc Salit·BMC GenomicsPeer-reviewed·Sep 17, 2015
- Comparison of miRNA profiling methods using synthetic miRNA pools and standardized exRNA samples reveals substantial performance differences
Paula M. Godoy, Andrea J. Barczak, … Louise Chang Laurent·bioRxiv·May 24, 2019
- Femtomolar-level PCR-free quantification of microRNA cancer biomarkers in serum
A. Kanavarioti·bioRxiv·Dec 30, 2022
- An assessment of normalization and differential expression methods for miRNA-seq analysis using a realistic benchmark dataset
Ernesto Aparicio‐Puerta, Andrea M Baran, … Matthew N. McCall·bioRxiv·May 13, 2026
- Small RNA-sequencing for Analysis of Circulating miRNAs: Benchmark Study
Peter Androvic, Sarka Benesova, … Lukáš Valihrach·Journal of Molecular DiagnosticsPeer-reviewed·Jan 23, 2022
- Selection of reference genes for quantitative analysis of microRNA expression in three cancers.
Yu. A. Veryaskina, Sergei Evgenievich Titov, … Igor Fyodorovich Zhimulev·bioRxiv·Jul 23, 2021